论文信息 - SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance - 字舞流文

SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance

M. Tran-Dube | M. McTigue | S. Yamazaki | C. Dillon | A. Brooun | C. Chung | E. McMillan | K. Maegley | Fen Wang | E. Rui | T. Paul | M. Wythes | K. Jensen-Pergakes | T. Xie | Hieu Lam | Prakash B. Palde | Wei Liu | S. Scales | J. Tatlock | R. Kumpf | S. Kephart | Ya-Li Deng | Manli Shi | J. Sherrill | Yuli Wang | Eleanore Hendrickson | Noah Spiegel | J. Braganza | Indrawan J. McAlpine | Ryan L. Patman | S. Bryant | Amy N. Nemeth | Natalie Miller | Vesta Goshtasbi